DONGWHA PHARM CO LTD

http://dongwhap.tradekorea.com

Dong Wha is the company that “serves customers through making good medicines and is operated with the resulting revenues.” And it considers its customers’ health and safety to be the most important corporate philosophy on which to fulfill customer satisfaction. Dong Wha members consider themselves to be the owner of the company where “they are willing to work diligently in their youth and live fruitful lives in their old age.” Dong Wha respects each member’s value and ownership and serves every customer with trust and faith. Dong Wha announced the year 2008 to be the year of the beginning of change & innovation for sustainable growth and it pursues creativity development and quality improvement of every member and flexible innovation to corporate culture to rise up as the major player in global pharmaceutical business in the 21st century. Moreover, based on accumulated experiences and technologies from the 114 year history, Dong Wha succeeded in several new drug developments, including licensing-out of DW 1350 (anti-osteoporosis) to P&G (US) and Teijin (Japan) which was the largest technology transfer in the Korean pharmaceutical industry.